Diets don't fail. Your biology does.

You did not fail your last diet. The diet failed you. The system you were fighting was not a lack of willpower. It was a measurable, hormonal, metabolic counter-attack engineered over thirty thousand years of food scarcity. When your body senses sustained weight loss, it does not negotiate. It re-tunes the hardware.

The success rate for keeping diet-induced weight off for five years sits somewhere between 5 and 20 percent, depending on which review you accept. The generous reads are the ones funded by the industry selling the next plan. The honest read is that, for the average adult, restrictive dieting is one of the worst long-term interventions for body composition, and the people selling it know this.

What follows is what the literature actually says about why diets collapse. None of it is a moral failure on your part. All of it changes what a sane plan looks like.

The most-cited indictment of dieting is a 2007 review in American Psychologist (Mann et al, UCLA, 31 long-term dieting studies). The conclusion was that one third to two thirds of dieters regained more weight than they lost, and that the studies likely understated the failure rate due to selection bias and short follow-up. The authors recommended that Medicare not fund weight-loss programs for obesity. Two decades on, the evidence has only consolidated.

The mechanism is metabolic, not motivational. The Fothergill et al follow-up of "Biggest Loser" contestants in the journal Obesity in 2016 tracked 14 of the 16 finalists for 6 years after their season. They had lost an average of 58 kg. They had regained 41 kg by year 6. More damaging, their resting metabolic rate was still about 700 calories per day below baseline. They were burning 700 fewer calories at rest than people of the same body weight who had never dieted. The adaptation did not relax with time. It got entrenched.

A separate Australian study, Sumithran et al in the New England Journal of Medicine in 2011, put 50 overweight adults on a 10-week very-low-energy diet and followed them for a year. After the average 13.5 kg weight loss, leptin, peptide YY, and cholecystokinin, the hormones that signal "stop eating", all dropped significantly. Ghrelin, the hormone that signals "eat", rose. A year later, none of the hormones had returned to baseline. Hunger ratings were still significantly elevated. Your body, in other words, was still actively trying to refill the deficit twelve months after the program ended.

The hardest single piece of evidence comes from the largest behavioural weight-loss trial ever run. The Look AHEAD trial in the New England Journal of Medicine in 2013 randomised 5,145 overweight adults with type 2 diabetes to an intensive lifestyle intervention or standard care. The intervention group received calorie targets, supervised exercise, group sessions, meal replacements, and nearly a decade of structured follow-up. They did achieve sustained weight loss, about 6 percent at the end of the trial. And they had no reduction in cardiovascular events compared with the control group. The trial was stopped early for futility.

The 10 percent who do keep the weight off look nothing like the diet they used. The 10-year follow-up of the National Weight Control Registry (Thomas et al, American Journal of Preventive Medicine 2014, 2,886 adults) showed durable maintainers had lost 31.3 kg on average at baseline and were still down 23.1 kg a decade later. The behaviours they share are about 60 minutes a day of physical activity, weekly self-weighing, eating breakfast, and consistent eating patterns across weekdays and weekends. They do not share a diet. They share a permanent set of habits.

GLP-1 drugs, sold as Ozempic, Wegovy, Mounjaro, and Zepbound, are the first intervention in fifty years that actually targets the biology Sumithran measured.

They work by mimicking a gut hormone that suppresses appetite, slows stomach emptying, and quiets the food noise that ghrelin amplifies after a diet. They do, pharmacologically, what willpower cannot reliably do. The STEP 1 trial of semaglutide (Wilding et al, New England Journal of Medicine 2021, 1,961 adults, 68 weeks) showed average weight loss of 14.9 percent versus 2.4 percent on placebo. The SURMOUNT-1 trial of tirzepatide (Jastreboff et al, New England Journal of Medicine 2022, 2,539 adults, 72 weeks) reached 20.9 percent at the highest dose. Numbers no behavioural intervention has ever produced.

The catch sits in the same biology. When Rubino et al ran a randomised withdrawal trial in JAMA in 2021, participants who had reached steady weight loss on semaglutide and were then switched to placebo regained about two-thirds of it inside a year.

Even the most powerful weight-loss drugs ever made end in the same place every diet ends. Stop, and your body is built to put the weight back on.

You are not weak. You were running an intervention the biology was built to defeat. Now that you understand the machinery, the four leverage points below work with it, not against it. None of them require willpower.

First, drop the framing of a diet entirely. Pick an eating pattern you could imagine still doing in 2036. The Mediterranean pattern has the strongest long-term evidence for both weight stability and cardiovascular outcomes, and it asks for almost nothing in willpower because it is built around foods most people enjoy. A pattern you can sustain never triggers the famine response in the first place.

Second, build muscle. Resting metabolic rate is largely set by lean mass, and lean mass is what the metabolic adaptation in Fothergill comes for first. Two strength sessions a week, with progressive overload, actively push back on the 700-calorie deficit Fothergill measured. Cardio alone, at any volume, does not.

Third, weigh yourself once a week, not every day, same morning, and write the number down. The Registry data is consistent on this. Daily weighing breeds defeatism. A weekly trend line catches drift early, while a 1 kg correction is still a 1 kg correction.

Fourth, treat hunger as data, not as a test of character. If you are persistently hungry on a plan, it is the wrong plan. Ghrelin will outlast your motivation. The plan you can eat without deprivation is the plan that survives.

If you are on a GLP-1 or considering one, the four leverage points above are not optional add-ons. They are the only thing that survives the day you stop the drug.

If you have been on three diets in the last five years and weigh more now than when you started the first one, you are not the failure. You are the predictable output of an intervention that does not work at scale. The action this week is unglamorous and entirely within your control. This Sunday morning, weigh yourself once and write the number down. Then pick the eating pattern you would still be eating in 2036, and start building from there.